Home/Filings/4/0001209191-17-002703
4//SEC Filing

Spring Bank Pharmaceuticals, Inc. 4

Accession 0001209191-17-002703

CIK 0001566373operating

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:24 PM ET

Size

6.8 KB

Accession

0001209191-17-002703

Insider Transaction Report

Form 4
Period: 2016-12-30
Transactions
  • Award

    Common Stock

    2016-12-30+3,520505,610 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    19,791
  • Common Stock

    (indirect: See Footnote)
    10,000
Footnotes (3)
  • [F1]The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member.
  • [F2]These shares are directly held by Theresa Eichler as custodian for Katherine Eichler UGMA NJ. Teresa Eichler and Katherine Eichler are immediate family members sharing a household with the Reporting Person.
  • [F3]These shares are directly held by the Kurt M. Eichler Trust Under Agreement dated 12/27/14 FBO Katherine Eichler (the "Katherine Eichler Trust"). The Reporting Person's immediate family member, Katherine Eichler, is a beneficiary of the Katherine Eichler Trust, and the Reporting Person is a trustee of the Katherine Eichler Trust.

Issuer

Spring Bank Pharmaceuticals, Inc.

CIK 0001566373

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001566373

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:24 PM ET
Size
6.8 KB